Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes

DOI: 10.1080/2162402X.2017.1356152

Keywords: antithymocyte globulin, graft-vs.-host disease, haploidentical stem cell transplantation, immune reconstitution, post-transplant cyclophosphamide, regulatory T cells

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text